What is the ROE (Return on Equity) of Augmedix this year?
The ROE of Augmedix this year is -0.82 undefined.
Augmedix ROE 2024
Augmedix ROE
-0.82
Ticker
AUGX
ISIN
US05105P1075
In 2024, Augmedix's return on equity (ROE) was -0.82, a -95.06% increase from the -16.63 ROE in the previous year.
Augmedix Aktienanalyse
What does Augmedix do?
Augmedix Inc. is a San Francisco-based company specializing in the development of technologies and software to assist medical professionals. It was founded in 2012 by Ian Shakil and Pelu Tran to change the way doctors capture and document patient data. The decision to start Augmedix was influenced by the personal experiences of the two founders. While working in the emergency room, Shakil noticed that he was constantly turning his back on his patients to create medical records, which took away from the actual treatment and interrupted visual contact with the patient. Based on his experiences, he saw an opportunity to help doctors focus more on their patients. Pelu Tran, the other founder, also worked in the healthcare industry and wanted to help doctors and nurses have more time for patient care. Augmedix's business model is based on the integration of speech technology and virtual reality. Augmedix has developed specialized software that directs doctors' attention away from data entry and towards treating their patients. Instead of focusing on writing notes, dictation, and clarifying paper notes, doctors can speak directly to a virtual assistant in real-time, who automates their records and embeds them into their medical records. Through this process automation, doctors can spend more time caring for their patients. Augmedix has now specialized in various areas within medical technology. For example, Augmedix offers speech technology platforms that surgical teams can use to access patient information and follow care protocols during surgery without leaving the operating table. There are also wireless mobile headsets that allow doctors to access patient information and create notes during patient treatment without interrupting contact between the doctor and patient. Augmedix also offers a telemedicine telepresence system that allows doctors and patients to communicate with each other via video calls. The system provides a convenient way for both patients and doctors to conduct and receive video consultations without the need for physical presence. Augmedix has become a major player in the digital healthcare industry, especially for doctors and hospitals. The company has already gained many customers in the US healthcare sector, including dozens of leading clinic chains. With its unique business model, Augmedix has taken a pioneering role in introducing new technologies in healthcare. In collaboration with the cloud computing platform Google Cloud, a dedicated medical security cloud platform and application for the healthcare industry are now being developed. Augmedix and Google Cloud now enable doctors to send medical data in real-time to their Augmedix virtual assistant and simultaneously update existing HIPAA-compliant patient records. Overall, Augmedix has become an important company for the introduction of new technologies in healthcare and can be proud to support doctors in their work and optimize healthcare for patients. Augmedix ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Augmedix's Return on Equity (ROE)
Augmedix's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Augmedix's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Augmedix's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Augmedix’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Augmedix stock
How has the Return on Equity (ROE) of Augmedix developed compared to the previous year?
The ROE of Augmedix has increased by -95.06% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Augmedix?
A high ROE indicates that Augmedix generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Augmedix?
A low ROE can indicate that Augmedix is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Augmedix affect the company?
A change in ROE (Return on Equity) of Augmedix can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Augmedix?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Augmedix?
Some factors that can influence Augmedix's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Augmedix pay?
Over the past 12 months, Augmedix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Augmedix is expected to pay a dividend of 0 USD.
What is the dividend yield of Augmedix?
The current dividend yield of Augmedix is .
When does Augmedix pay dividends?
Augmedix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Augmedix?
Augmedix paid dividends every year for the past 0 years.
What is the dividend of Augmedix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Augmedix located?
Augmedix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Augmedix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Augmedix from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did Augmedix pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of Augmedix in the year 2023?
In the year 2023, Augmedix distributed 0 USD as dividends.
In which currency does Augmedix pay out the dividend?
The dividends of Augmedix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Augmedix
Our stock analysis for Augmedix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Augmedix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.